Schedule 13D ownership disclosure

TSCAN THERAPEUTICS INC

Security class unavailable · CUSIP: 89854M101

Event date: 2022-05-10

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,784,792
Percent of class
14.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-22-059502
Form type
SC 13D/A
Filer
BAKER BROS. ADVISORS LP
CIK
CIK 1263508
Filed
May 12, 2022
Reporting period
May 10, 2022
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub